CCR5-gene-modified adipose stem cell-based therapy (RNL Bio/ToolGen)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCCR5-gene-modified adipose stem cell-based therapy (RNL Bio/ToolGen)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapy
Mechanisms of ActionC-C chemokine receptor type 5 modulators
TargetsC-C chemokine receptor type 5
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRNL Bio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesToolGen IncRNL Bio Co Ltd
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A